Search &amp; screen the market by signal.

$1.01T

+1.8% 1D

$1229.93

P/E

49.0

P/S

15.5

Net mgn

31.7%

95th pct

Rev gro

44.7%

79th pct

2ABBVNYSE🔥

AbbVie Inc.

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

27 shown

Aug 9, 2016·10y ago·Strategic

Material Agreement · Equity Issuance

DHRDANAHER CORP /DE/

Filings current to Jun 29 · prices to Jun 29. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Floor: $50M market cap, $1 price.

$402.4B

+0.4% 1D

$254.31

P/E

110.5

P/S

6.4

Net mgn

5.8%

75th pct

Rev gro

12.6%

57th pct

Dilution · Feb '26Red 8-K · Jan '25

3UNHNYSE🔥

UNITEDHEALTH GROUP INC

$371.0B

-1.9% 1D

$419.82

P/E

29.0

P/S

0.8

Net mgn

2.8%

69th pct

Rev gro

11.8%

56th pct

Dilution · Jun '25

4MRKNYSE⚡

Merck & Co., Inc.

$294.0B

+0.6% 1D

$129.38

P/E

32.9

P/S

4.5

Net mgn

13.6%

87th pct

Rev gro

1.3%

39th pct

Dilution · 41d ago

5AZNNYSE🔥

ASTRAZENECA PLC

$277.2B

+1.4% 1D

$190.95

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Feb '26

6GLWNYSE🔥

CORNING INC /NY

Materials

$154.2B

+15.7% 1D

$255.69

P/E

78.5

P/S

9.4

Net mgn

12.0%

80th pct

Rev gro

19.1%

88th pct

7VRTXNASDAQ🔥

VERTEX PHARMACEUTICALS INC / MA

$112.9B

+1.7% 1D

$499.65

P/E

26.0

P/S

9.2

Net mgn

35.5%

95th pct

Rev gro

8.9%

52nd pct

Red 8-K

8MCKNYSE⚡

MCKESSON CORP

$94.2B

-2.1% 1D

$747.53

P/E

18.5

P/S

0.2

Net mgn

1.3%

67th pct

Rev gro

12.4%

56th pct

Dilution · May '25

9ALNYNASDAQ

ALNYLAM PHARMACEUTICALS, INC.

$37.8B

+0.7% 1D

$293.52

P/E

120.4

P/S

10.2

Net mgn

8.4%

80th pct

Rev gro

65.2%

84th pct

Red 8-K

10ANYSE🔥

AGILENT TECHNOLOGIES, INC.

$36.7B

-2.3% 1D

$132.83

P/E

25.9

P/S

5.1

Net mgn

19.6%

91st pct

Rev gro

1.7%

40th pct

Red 8-K

11WATNYSE⚡

WATERS CORP /DE/

$34.9B

-1.5% 1D

$368.87

P/E

54.3

P/S

11.0

Net mgn

20.3%

91st pct

Rev gro

7.0%

48th pct

12NTRANASDAQ🔥

Natera, Inc.

$30.4B

+4.0% 1D

$272.31

P/E

—

P/S

12.1

Net mgn

-9.0%

57th pct

Rev gro

35.9%

75th pct

Red 8-K

13IQVNYSE⚡

IQVIA HOLDINGS INC.

$30.3B

+1.1% 1D

$193.28

P/E

22.3

P/S

1.9

Net mgn

8.3%

80th pct

Rev gro

5.9%

46th pct

Red 8-K

14BIIBNASDAQ

BIOGEN INC.

$29.5B

+0.3% 1D

$216.63

P/E

21.5

P/S

3.0

Net mgn

13.8%

87th pct

Rev gro

0.6%

37th pct

13D · May '26

15DOVNYSE⚡

DOVER Corp

$29.3B

-0.9% 1D

$224.00

P/E

26.6

P/S

3.5

Net mgn

13.3%

84th pct

Rev gro

-4.1%

25th pct

16UTHRNASDAQ⚡

UNITED THERAPEUTICS Corp

$23.2B

+0.4% 1D

$544.92

P/E

18.0

P/S

7.3

Net mgn

40.6%

96th pct

Rev gro

10.6%

54th pct

Red 8-K

17LHNYSE⚡

LABCORP HOLDINGS INC.

$21.8B

+3.0% 1D

$279.58

P/E

23.2

P/S

1.5

Net mgn

6.7%

77th pct

Rev gro

7.2%

49th pct

18INSMNASDAQ

INSMED Inc

$21.2B

+1.3% 1D

$104.74

P/E

—

P/S

25.9

Net mgn

-144.4%

29th pct

Rev gro

66.7%

85th pct

Dilution · Jun '25

19MRNANASDAQ🔥

Moderna, Inc.

$19.8B

+3.6% 1D

$69.70

P/E

—

P/S

8.9

Net mgn

-143.6%

29th pct

Rev gro

-39.9%

15th pct

20GHNASDAQ⚡

Guardant Health, Inc.

$17.5B

+3.0% 1D

$153.74

P/E

—

P/S

16.2

Net mgn

-40.1%

42nd pct

Rev gro

32.9%

74th pct

Dilution · Nov '25Red 8-K

21NBIXNASDAQ

NEUROCRINE BIOSCIENCES INC

$16.1B

+0.9% 1D

$170.00

P/E

24.0

P/S

5.2

Net mgn

21.6%

92nd pct

Rev gro

51.6%

80th pct

Red 8-K

22EXELNASDAQ

EXELIXIS, INC.

$13.4B

-0.9% 1D

$54.28

P/E

25.6

P/S

6.2

Net mgn

24.0%

92nd pct

Rev gro

18.5%

63rd pct

13D · Jan '26Red 8-K

23BBIONASDAQ

BridgeBio Pharma, Inc.

$13.1B

+2.5% 1D

$72.01

P/E

—

P/S

22.6

Net mgn

-125.9%

31st pct

Rev gro

126.3%

90th pct

13D · Apr '26Red 8-K

24IONSNASDAQ

IONIS PHARMACEUTICALS INC

$12.1B

-0.6% 1D

$80.69

P/E

—

P/S

11.4

Net mgn

-30.9%

46th pct

Rev gro

33.8%

75th pct

Red 8-K

25RVTYNYSE🔥

REVVITY, INC.

$11.1B

-1.6% 1D

$111.21

P/E

46.1

P/S

3.9

Net mgn

8.4%

80th pct

Rev gro

3.7%

41st pct

26MDGLNASDAQ

MADRIGAL PHARMACEUTICALS, INC.

$11.1B

+2.9% 1D

$527.28

P/E

—

P/S

9.8

Net mgn

-27.3%

48th pct

Rev gro

432.1%

95th pct

13D · Dec '25Red 8-K

27RDYNYSE

DR REDDYS LABORATORIES LTD

$11.1B

-3.4% 1D

$14.86

P/E

—

P/S

—

Net mgn

—

Rev gro

—

28SMMTNASDAQ🔥

Summit Therapeutics Inc.

$10.9B

+2.2% 1D

$14.32

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · 20d ago

29BMRNNASDAQ

BIOMARIN PHARMACEUTICAL INC

$10.8B

-2.3% 1D

$57.67

P/E

40.2

P/S

3.3

Net mgn

8.3%

79th pct

Rev gro

12.9%

57th pct

Red 8-K

30ARWRNASDAQ

ARROWHEAD PHARMACEUTICALS, INC.

$10.5B

+2.0% 1D

$80.50

P/E

—

P/S

16.9

Net mgn

-43.7%

41st pct

Rev gro

23258.2%

100th pct

Dilution · Jan '26Red 8-K

31DCINYSE

DONALDSON Co INC

$10.0B

-0.1% 1D

$88.40

P/E

22.8

P/S

2.6

Net mgn

11.5%

79th pct

Rev gro

2.9%

47th pct

32KRYSNASDAQ⚡

Krystal Biotech, Inc.

$9.4B

+1.6% 1D

$378.15

P/E

41.7

P/S

22.5

Net mgn

53.9%

97th pct

Rev gro

667.5%

96th pct

33CRLNYSE🔥

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

$9.0B

+4.5% 1D

$225.57

P/E

—

P/S

2.2

Net mgn

-4.5%

61st pct

Rev gro

-0.9%

34th pct

Red 8-K

34TECHNASDAQ🔥

BIO-TECHNE Corp

$8.5B

-0.1% 1D

$70.90

P/E

77.2

P/S

7.0

Net mgn

9.0%

81st pct

Rev gro

5.2%

45th pct

Red 8-K

35PRAXNASDAQ⚡

Praxis Precision Medicines, Inc.

$7.4B

+7.0% 1D

$350.56

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Jan '26

36RGENNASDAQ

REPLIGEN CORP

$7.4B

-6.8% 1D

$137.00

P/E

143.3

P/S

9.7

Net mgn

6.7%

77th pct

Rev gro

16.4%

61st pct

37KYMRNASDAQ⚡

Kymera Therapeutics, Inc.

$7.1B

+1.1% 1D

$109.32

P/E

—

P/S

180.8

Net mgn

-794.0%

12th pct

Rev gro

-16.7%

21st pct

13D · 4d agoDilution · Feb '26Red 8-K

38PTCTNASDAQ

PTC THERAPEUTICS, INC.

$6.2B

-3.4% 1D

$81.57

P/E

—

P/S

7.5

Net mgn

-22.6%

49th pct

Rev gro

84.5%

87th pct

Red 8-K

39RYTMNASDAQ⚡

RHYTHM PHARMACEUTICALS, INC.

$6.1B

+0.2% 1D

$110.04

P/E

—

P/S

27.9

Net mgn

-93.3%

34th pct

Rev gro

45.8%

79th pct

Dilution · Jul '25Red 8-K

40MIRMNASDAQ

Mirum Pharmaceuticals, Inc.

$6.1B

-0.6% 1D

$123.00

P/E

—

P/S

10.6

Net mgn

-140.2%

30th pct

Rev gro

54.7%

81st pct

13D · Jan '26

41SRRKNASDAQ

Scholar Rock Holding Corp

$5.3B

+0.4% 1D

$54.96

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Nov '25Red 8-K · Jun '25

42CAINASDAQ

Caris Life Sciences, Inc.

$5.1B

-1.0% 1D

$18.32

P/E

149.5

P/S

5.6

Net mgn

3.7%

72nd pct

Rev gro

176.2%

92nd pct

Dilution · Jun '25

43CRSPNASDAQ⚡

CRISPR Therapeutics AG

$4.9B

+2.6% 1D

$56.35

P/E

—

P/S

1195.3

Net mgn

-13856.5%

0th pct

Rev gro

-90.6%

6th pct

Dilution · Oct '25Red 8-K

44TVTXNASDAQ⚡

Travere Therapeutics, Inc.

$4.8B

-0.9% 1D

$58.30

P/E

—

P/S

9.0

Net mgn

-4.0%

61st pct

Rev gro

237.9%

93rd pct

Dilution · May '26Red 8-K

45TWSTNASDAQ

Twist Bioscience Corp

$4.7B

-1.5% 1D

$98.36

P/E

—

P/S

11.6

Net mgn

-19.8%

50th pct

Rev gro

20.3%

65th pct

46BLLNNASDAQ⚡

BillionToOne, Inc.

$4.7B

+1.9% 1D

$120.40

P/E

158.1

P/S

13.1

Net mgn

8.3%

79th pct

Rev gro

—

13D · Jan '26Dilution · Nov '25

47DNTHNASDAQ⚡

Dianthus Therapeutics, Inc. /DE/

$4.5B

+0.3% 1D

$95.68

P/E

—

P/S

2203.6

Net mgn

-7973.3%

1st pct

Rev gro

-67.3%

9th pct

Dilution · Mar '26

48CELCNASDAQ⚡

Celcuity Inc.

$4.3B

+2.6% 1D

$102.52

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Mar '26Dilution · 25d agoRed 8-K

49ORKANASDAQ

Oruka Therapeutics, Inc.

$4.2B

+2.1% 1D

$92.49

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · May '26Dilution · Apr '26

50EWTXNASDAQ⚡

Edgewise Therapeutics, Inc.

$3.7B

-1.3% 1D

$40.92

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Apr '26Dilution · Apr '25

51DNLINASDAQ

Denali Therapeutics Inc.

$3.4B

+1.3% 1D

$25.89

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Dec '25

52ALMSNASDAQ

ALUMIS INC.

$3.1B

+2.8% 1D

$27.14

P/E

—

P/S

366.5

Net mgn

-2825.7%

5th pct

Rev gro

—

13D · Apr '26Dilution · Jan '26

53ADPTNASDAQ

Adaptive Biotechnologies Corp

$2.8B

+2.1% 1D

$21.40

P/E

—

P/S

9.5

Net mgn

-16.8%

52nd pct

Rev gro

62.7%

83rd pct

54RARENASDAQ

Ultragenyx Pharmaceutical Inc.

$2.4B

-0.3% 1D

$30.68

P/E

—

P/S

3.6

Net mgn

-90.9%

34th pct

Rev gro

55.0%

82nd pct

Red 8-K

55KODNASDAQ

Kodiak Sciences Inc.

$2.1B

+5.0% 1D

$37.74

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Dec '25Dilution · Dec '25

56IMNMNASDAQ

Immunome Inc.

$2.1B

+5.4% 1D

$21.04

P/E

—

P/S

518.4

Net mgn

-5593.8%

1st pct

Rev gro

-23.2%

19th pct

13D · Dec '25Dilution · Dec '25

57HRMYNASDAQ

Harmony Biosciences Holdings, Inc.

$2.0B

-0.4% 1D

$35.34

P/E

13.7

P/S

2.2

Net mgn

16.2%

89th pct

Rev gro

21.5%

67th pct

Red 8-K

58IOVANASDAQ

IOVANCE BIOTHERAPEUTICS, INC.

$1.8B

-0.9% 1D

$4.21

P/E

—

P/S

1532.2

Net mgn

-37345.4%

0th pct

Rev gro

—

Dilution · Aug '25

59NRIXNASDAQ🔥

Nurix Therapeutics, Inc.

$1.8B

+4.2% 1D

$23.85

P/E

—

P/S

24.4

Net mgn

-411.4%

19th pct

Rev gro

—

Dilution · Mar '26

60AGIONASDAQ

AGIOS PHARMACEUTICALS, INC.

$1.8B

+0.4% 1D

$38.04

P/E

—

P/S

26.5

Net mgn

-639.8%

14th pct

Rev gro

48.0%

80th pct

Red 8-K

61QURENASDAQ🔥

uniQure N.V.

$1.7B

-0.3% 1D

$47.39

P/E

—

P/S

96.1

Net mgn

-1154.4%

9th pct

Rev gro

1.6%

40th pct

Dilution · 6d agoRed 8-K

62NTLANASDAQ⚡

Intellia Therapeutics, Inc.

$1.7B

-0.4% 1D

$16.61

P/E

—

P/S

25.6

Net mgn

-597.0%

15th pct

Rev gro

86.5%

87th pct

Dilution · Apr '26

63INVANASDAQ

Innoviva, Inc.

$1.7B

-1.8% 1D

$23.14

P/E

6.2

P/S

4.1

Net mgn

65.9%

98th pct

Rev gro

14.7%

59th pct

Red 8-K

64RXRXNASDAQ

RECURSION PHARMACEUTICALS, INC.

$1.7B

+4.8% 1D

$3.69

P/E

—

P/S

22.4

Net mgn

-863.4%

11th pct

Rev gro

26.9%

70th pct

13D · Dec '25Dilution · Feb '26Red 8-K

65TSHANASDAQ

Taysha Gene Therapies, Inc.

$1.6B

+6.2% 1D

$6.73

P/E

—

P/S

219.6

Net mgn

-1738.4%

7th pct

Rev gro

17.3%

62nd pct

Dilution · 5d ago

66CMPSNASDAQ

COMPASS Pathways plc

$1.6B

+1.7% 1D

$15.07

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Feb '26Red 8-K · Apr '25

67AMLXNASDAQ

Amylyx Pharmaceuticals, Inc.

$1.6B

+5.1% 1D

$18.70

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

Dilution · Sep '25

68SIONNASDAQ

Sionna Therapeutics, Inc.

$1.6B

+1.9% 1D

$42.97

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Apr '26Dilution · Feb '25

69SRPTNASDAQ

Sarepta Therapeutics, Inc.

$1.6B

+1.0% 1D

$17.02

P/E

—

P/S

0.7

Net mgn

-32.5%

46th pct

Rev gro

15.6%

60th pct

Red 8-K

70PGENNASDAQ

PRECIGEN, INC.

$1.6B

+1.0% 1D

$5.92

P/E

—

P/S

50.2

Net mgn

-647.0%

14th pct

Rev gro

—

13D · Mar '26Red 8-K

71FTRENASDAQ

Fortrea Holdings Inc.

$1.6B

-0.7% 1D

$17.52

P/E

—

P/S

0.6

Net mgn

-16.5%

53rd pct

Rev gro

-12.4%

23rd pct

Red 8-K

72SLSNASDAQ

SELLAS Life Sciences Group, Inc.

$1.5B

+24.7% 1D

$15.45

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Oct '25Red 8-K · Jun '25

73CAPRNASDAQ

CAPRICOR THERAPEUTICS, INC.

$1.5B

-10.0% 1D

$23.80

P/E

—

P/S

67.1

Net mgn

-181.7%

26th pct

Rev gro

-11.5%

23rd pct

Dilution · Dec '25

74NEONASDAQ

NEOGENOMICS INC

$1.5B

+0.6% 1D

$14.25

P/E

—

P/S

2.0

Net mgn

-14.9%

14th pct

Rev gro

10.1%

71st pct

Red 8-K

75AVBPNASDAQ

ArriVent BioPharma, Inc.

$1.4B

+1.1% 1D

$34.37

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · May '26Red 8-K · Mar '25

76MLTXNASDAQ

MoonLake Immunotherapeutics

$1.4B

+0.1% 1D

$19.91

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · 1d agoDilution · 6d agoRed 8-K

77BLFSNASDAQ

BIOLIFE SOLUTIONS INC

$1.3B

-1.3% 1D

$28.30

P/E

—

P/S

12.8

Net mgn

-3.0%

62nd pct

Rev gro

-32.8%

17th pct

13D · 39d ago

78CDNANASDAQ

CareDx, Inc.

$1.2B

+1.6% 1D

$29.28

P/E

—

P/S

2.9

Net mgn

-2.0%

63rd pct

Rev gro

35.5%

75th pct

Red 8-K

79WVENASDAQ

Wave Life Sciences Ltd.

$1.1B

-2.6% 1D

$5.68

P/E

—

P/S

15.7

Net mgn

-255.7%

23rd pct

Rev gro

-60.5%

10th pct

13D · Apr '26Dilution · Dec '25

80AZTANASDAQ

Azenta, Inc.

$1.0B

+0.0% 1D

$25.51

P/E

—

P/S

1.7

Net mgn

-29.1%

10th pct

Rev gro

-10.7%

14th pct

Red 8-K

81PCRXNASDAQ

Pacira BioSciences, Inc.

$905M

-0.6% 1D

$25.09

P/E

128.6

P/S

1.2

Net mgn

1.0%

67th pct

Rev gro

7.6%

50th pct

13D · Mar '26Red 8-K

82PHARNASDAQ

Pharming Group N.V.

$904M

+0.5% 1D

$13.40

P/E

—

P/S

—

Net mgn

—

Rev gro

—

83MGTXNASDAQ

MeiraGTx Holdings plc

$888M

+3.5% 1D

$12.54

P/E

—

P/S

11.1

Net mgn

-151.1%

28th pct

Rev gro

144.6%

91st pct

13D · Apr '26Dilution · Apr '26

84OLMANASDAQ

Olema Pharmaceuticals, Inc.

$862M

+7.1% 1D

$12.20

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Nov '25Red 8-K

85LXRXNASDAQ

LEXICON PHARMACEUTICALS, INC.

$853M

+3.5% 1D

$2.64

P/E

—

P/S

12.2

Net mgn

-37.5%

44th pct

Rev gro

60.2%

83rd pct

13D · May '26Dilution · Feb '26Red 8-K · Jan '25

86ABUSNASDAQ

Arbutus Biopharma Corp

$842M

+2.2% 1D

$4.68

P/E

5.2

P/S

4.4

Net mgn

84.0%

98th pct

Rev gro

128.2%

90th pct

13D · Apr '26Red 8-K

87JANXNASDAQ

Janux Therapeutics, Inc.

$827M

+2.6% 1D

$15.32

P/E

—

P/S

60.2

Net mgn

-833.6%

12th pct

Rev gro

-5.6%

27th pct

Red 8-K

88BIOANASDAQ

BioAge Labs, Inc.

$802M

+5.0% 1D

$24.95

P/E

—

P/S

77.7

Net mgn

-871.8%

11th pct

Rev gro

—

Dilution · Jan '26

89ZVRANASDAQ

ZEVRA THERAPEUTICS, INC.

$748M

+3.6% 1D

$14.01

P/E

9.0

P/S

7.0

Net mgn

78.2%

98th pct

Rev gro

350.9%

94th pct

90SANANASDAQ

Sana Biotechnology, Inc.

$746M

+0.9% 1D

$3.45

P/E

—

P/S

—

Net mgn

—

Rev gro

—

Dilution · Apr '26Red 8-K

91CYRXNASDAQ

Cryoport, Inc.

$737M

+1.8% 1D

$16.28

P/E

9.4

P/S

4.2

Net mgn

44.4%

96th pct

Rev gro

-22.9%

20th pct

92REPLNASDAQ

Replimune Group, Inc.

$733M

-3.7% 1D

$11.20

P/E

—

P/S

—

Net mgn

—

Rev gro

—

93SLDBNASDAQ

Solid Biosciences Inc.

$703M

+1.9% 1D

$9.47

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · 6d agoDilution · May '25Red 8-K

94CRMDNASDAQ

CorMedix Inc.

$686M

-2.7% 1D

$7.64

P/E

3.8

P/S

1.7

Net mgn

45.2%

96th pct

Rev gro

617.0%

96th pct

Dilution · Jun '25Red 8-K · Apr '25

95ALLONASDAQ

Allogene Therapeutics, Inc.

$656M

+4.2% 1D

$2.22

P/E

—

P/S

—

Net mgn

—

Rev gro

-100.0%

0th pct

13D · Feb '26Dilution · 8d agoRed 8-K

96CTMXNASDAQ

CytomX Therapeutics, Inc.

$655M

+10.0% 1D

$3.74

P/E

—

P/S

18.4

Net mgn

-166.4%

27th pct

Rev gro

-44.8%

13th pct

Dilution · Mar '26Red 8-K · Feb '25

97CSTLNASDAQ

CASTLE BIOSCIENCES INC

$628M

+0.1% 1D

$24.32

P/E

—

P/S

1.8

Net mgn

-3.8%

61st pct

Rev gro

56.6%

82nd pct

98CADLNASDAQ

Candel Therapeutics, Inc.

$627M

+5.8% 1D

$10.36

P/E

—

P/S

—

Net mgn

—

Rev gro

—

13D · Mar '26Dilution · Feb '26Red 8-K

99RIGLNASDAQ

RIGEL PHARMACEUTICALS INC

$608M

+0.9% 1D

$39.04

P/E

1.7

P/S

2.0

Net mgn

121.5%

99th pct

Rev gro

64.1%

84th pct

Red 8-K

100GYRENASDAQ

GYRE THERAPEUTICS, INC.

$575M

+2.5% 1D

$6.45

P/E

—

P/S

4.9

Net mgn

-1.2%

64th pct

Rev gro

10.2%

53rd pct

13D · May '26Dilution · May '25Red 8-K

Reg FD Disclosure

Jan 18, 2023·3y ago·Routine

Aug 14, 2024·1y ago·Red Alert

Executive Change

Apr 29, 2025·1y ago·Routine

Company Update

May 17, 2022·4y ago·Strategic

Material Agreement · Reg FD Disclosure

Dec 26, 2019·6y ago·Routine

Company Update

Dec 10, 2019·6y ago·Routine

Company Update

Feb 13, 2019·7y ago·Red Alert

Executive Change · Reg FD Disclosure

Oct 16, 2017·8y ago·Routine

Company Update

LSTALISATA THERAPEUTICS, INC.

Aug 6, 2013·13y ago·Routine

Company Update

May 18, 2015·11y ago·Red Alert

Executive Change · Acquisition / Disposition

May 6, 2015·11y ago·Red Alert

Executive Change · Material Agreement

IFFINTERNATIONAL FLAVORS & FRAGRANCES INC

Oct 22, 2025·8mo ago·Red Alert

Executive Change

Feb 12, 2021·5y ago·Routine

Reg FD Disclosure

Nov 7, 2019·6y ago·Strategic

Material Agreement

Jul 25, 2019·7y ago·Routine

Reg FD Disclosure

Nov 6, 2018·7y ago·Strategic

Material Agreement · Reg FD Disclosure

Aug 16, 2018·7y ago·Routine

Reg FD Disclosure

Feb 3, 2017·9y ago·Routine

Company Update

PVCTPROVECTUS BIOPHARMACEUTICALS, INC.

Jun 5, 2008·18y ago·Red Alert

Executive Change